EUVIMEDEUVIMED entdecken
Crossref

TFG ‐Containing Fusions in Melanocytic Tumors: From Polymorphic Read‐Through Transcripts to Oncogenic Kinase Fusions

Haiming Tang iD, Sara DiNapoli, Purvil Sukhadia iD, David Kim iD, Klaus J Busam iD

Journal of Cutaneous Pathology · 2026-12 · 53 (12) · 1142-1147

DOI: 10.1111/cup.70162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 09.06.2026. Verfasst von Haiming Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Oncogene Proteins, Fusion, Skin Neoplasms, Melanoma, Receptor, trkC. Die Arbeit nennt 26 Literaturangaben. Gefördert von: NIH Clinical Center, Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular analysis has emerged as an important ancillary method for the diagnosis and treatment of melanocytic tumors. Test results are often helpful but can occasionally be confounding if an unfamiliar variant is identified. We report a series of melanocytic tumors, which were found to harbor a TFG gene fusion and their significance. Of 105 melanocytic tumors with gene fusions, 9 involved TGF (8.6%) . One tumor harbored a TFG::NTRK3 fusion, more precisely characterized as an NTRK3 fusion with TFG as the 5′ partner, the detection of which was diagnostically helpful by indicating the presence of a Spitz pathway. Eight cases exhibited a TFG::ADGRG7 fusion. Current evidence suggests that this recurrent event represents a polymorphic germline variant, possibly arising from read‐through transcription (intergenic splicing), rather than a biologically pathogenic driver. It should be noted that laboratory reporting practices vary, and not all laboratories report such transcripts in official molecular pathology reports. Recognition of such fusions is essential to avoid misinterpretation, particularly as fusion detection increasingly informs diagnosis and clinical decision‐making. These findings underscore the necessity of integrating molecular results with established clinicopathologic frameworks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene Proteins, FusionSkin NeoplasmsMelanomaReceptor, trkCHumansFemaleMaleMiddle AgedAdultAgedOncogene FusionVesicular Transport Proteins

Substanzen

Oncogene Proteins, FusionTFG protein, humanReceptor, trkCNTRK3 protein, humanVesicular Transport Proteins

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Melanoma Research Alliance, Washington, DC, USA.

ORCID-Profile: Haiming Tang, Purvil Sukhadia, David Kim, Klaus J Busam

Förderung

  • NIH Clinical Center
  • Clinical Center

Zitieren

APA

Tang, H., DiNapoli, S., Sukhadia, P., Kim, D., & Busam, K. J. (2026). TFG ‐Containing Fusions in Melanocytic Tumors: From Polymorphic Read‐Through Transcripts to Oncogenic Kinase Fusions. Journal of Cutaneous Pathology, 53(12), 1142-1147. https://doi.org/10.1111/cup.70162

Vancouver

Tang H, DiNapoli S, Sukhadia P, Kim D, Busam KJ. TFG ‐Containing Fusions in Melanocytic Tumors: From Polymorphic Read‐Through Transcripts to Oncogenic Kinase Fusions. Journal of Cutaneous Pathology. 2026;53(12):1142-1147. doi:10.1111/cup.70162

BibTeX
@article{Tang2026,
  author = {Tang, Haiming and DiNapoli, Sara and Sukhadia, Purvil and Kim, David and Busam, Klaus J},
  title = {TFG ‐Containing Fusions in Melanocytic Tumors: From Polymorphic Read‐Through Transcripts to Oncogenic Kinase Fusions},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  volume = {53},
  number = {12},
  pages = {1142--1147},
  doi = {10.1111/cup.70162}
}
Kostenlos starten →